# Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection

> **NCT01560468** · PHASE1 · TERMINATED · sponsor: **Schiano, Thomas D., MD** · enrollment: 10 (estimated)

## Conditions studied

- Hepatitis C Infection

## Interventions

- **DRUG:** ITX 5061

## Key facts

- **NCT ID:** NCT01560468
- **Lead sponsor:** Schiano, Thomas D., MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 10 (ESTIMATED)
- **Why stopped:** Financial Reasons
- **Last updated:** 2018-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01560468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01560468, "Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01560468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*